Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating rheumatoid arthritis

A rheumatoid, composition technology, applied in the field of medicine, can solve problems such as joint swelling and pain, affecting the quality of life, recurrent attacks, etc., and achieve significant effects

Inactive Publication Date: 2015-04-08
胡彦
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Rheumatoid arthritis is a type of autoimmune disease, which is relatively common. Its main clinical manifestations are joint swelling, pain, deformity, and repeated attacks, which lead to inconvenient movement of patients and affect the quality of life.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0018] Embodiment Decoction of the present invention

[0019] Weigh 3 grams of wangbuliuxing, 4 grams of chuanxiong, 6 grams of cassia twig, 3 grams of Morinda officinalis, 2 grams of twig, 25 grams of Dajindao, 10 grams of female wan, 10 grams of small rhizoma, and 8 grams of rhizome gram, 10 grams of fig, 10 grams of kapok, 10 grams of see serum, 10 grams of noon flower, 10 grams of long-tube false jasmine, 9 grams of two-color gentian, 15 grams of peacock tail, 15 grams of white ox gall, 7 grams of silk grass , 8 grams of auspicious grass, 6 grams of old gentleman's beard, 15 grams of angelica vine, 10 grams of Huihui beans, 7 grams of golden plum, 15 grams of lip vanilla, 7 grams of rapeseed seven, 9 grams of earthworm grass, 6 grams of light flower medicine , 9 grams of Liangwang tea, 15 grams of tamarind and 9 grams of licorice, add 8000 milliliters of water, heat and reflux for 3 hours in a flask equipped with a condenser tube, then filter to obtain filtrate 1 and filte...

experiment example

[0024] normal information

[0025] A total of 88 patients with rheumatoid arthritis admitted to our hospital from March 2013 to June 2014 were selected and divided into two groups. Among them, 44 cases in the treatment group were treated with the decoction in the embodiment; 44 cases in the control group were treated with Fengshi Hantong Tablets (purchased from Tongrentang, Z12020022), a Chinese patent medicine. Observe and compare the clinical efficacy of the two groups, and analyze the clinical efficacy of the decoction in the embodiment for treating rheumatoid arthritis. There is no significant difference in gender, age, symptoms, course of disease, severity of disease, etc. between the two groups of patients, and a controlled trial can be conducted. Among all the patients, there were 47 males and 41 females; their age ranged from 37 to 73 years old, with an average of (57.3±5.9) years old. All patients met the diagnostic criteria revised by the 51st meeting of the Americ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating rheumatoid arthritis, which comprises 1-5 parts of semen vaccariae, 1-10 parts of rhizoma ligustici chuanxiong, 5-10 parts of cassia twig, 1-5 parts of radix morindae officinalis, 1-5 parts of tuber fleeceflower stem and the like. The pharmaceutical composition provided by the invention has a remarkable effect on treating rheumatoid arthritis through interaction and synergism and deserves clinical promotion.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is a type of autoimmune disease, which is relatively common. Its main clinical manifestations are joint swelling, pain, deformity, and repeated attacks, which lead to inconvenient movement of patients and affect the quality of life. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating rheumatoid arthritis. [0004] In order to achieve the purpose of the present invention, the present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis, which comprises the following materials in parts by weight: 1-5 parts of Buliuxing, 1-10 parts of Rhizoma Chuanxiong, 5-5 parts of Guizhi 10 parts, 1-5 parts of Morinda officinalis and 1-5 parts of Yejiao vine. [0005] Preferably...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/746A61K36/898A61P19/02A61P29/00
CPCA61K36/36A61K9/0095A61K36/11A61K36/185A61K36/236A61K36/25A61K36/27A61K36/28A61K36/31A61K36/41A61K36/48A61K36/484A61K36/51A61K36/515A61K36/53A61K36/539A61K36/54A61K36/60A61K36/704A61K36/746A61K36/80A61K36/85A61K36/88A61K36/896A61K36/898A61K2300/00
Inventor 胡彦张圣魁
Owner 胡彦
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products